Drug profile · INN
eliglustat
CERDELGA
eliglustat (CERDELGA) is a ceramide glucosyltransferase inhibitor.
EMA: approved Alimentary tract and metabolism (A16) A16AX10
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — eliglustat
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
eliglustat (CERDELGA) is a ceramide glucosyltransferase inhibitor.
Key facts
INN eliglustat
Brand CERDELGA
Mechanism Ceramide glucosyltransferase inhibitor
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AX10
Mechanism of action
Ceramide glucosyltransferase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is eliglustat?
eliglustat (CERDELGA) is a ceramide glucosyltransferase inhibitor.
What is the brand name for eliglustat?
CERDELGA is a marketed brand name for eliglustat. Check FDA Drugs@FDA for the current US label holder and prescribing information.